Reducing the risk


Researchers investigating the link between omega-3 status and risk of preterm birth provide advice to pharmacists about OTC omega-3 products in pregnant women SA Pathology and the South Australian Health & Medical Research Institute (SAHMRI) are currently evaluating the feasibility and adoption of an omega-3 test-and-treat program to prevent preterm birth. Since May 2021 they

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Unwelcome surprise’ in store for pharmacy scope patients: docs
Next MedAdvisor to take over Project Stop